Bifogade filer
The Supreme Court denies to leave appeal
Kurs
+0,21%
Likviditet
4,66 MSEK
Prenumeration
Kalender
| Tid* | ||
| 2026-02-10 | 08:30 | Bokslutskommuniké 2025 |
| 2025-10-23 | 08:30 | Kvartalsrapport 2025-Q3 |
| 2025-07-18 | 08:30 | Kvartalsrapport 2025-Q2 |
| 2025-05-08 | - | Årsstämma |
| 2025-05-07 | 08:30 | Kvartalsrapport 2025-Q1 |
| 2025-02-07 | 08:30 | Bokslutskommuniké 2024 |
| 2024-10-23 | - | Kvartalsrapport 2024-Q3 |
| 2024-07-18 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-16 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
| 2024-05-15 | - | Årsstämma |
| 2024-05-14 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-08 | - | Bokslutskommuniké 2023 |
| 2023-10-27 | - | Kvartalsrapport 2023-Q3 |
| 2023-07-20 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-08 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
| 2023-05-05 | - | Årsstämma |
| 2023-05-05 | - | Kvartalsrapport 2023-Q1 |
| 2023-01-26 | - | Bokslutskommuniké 2022 |
| 2022-10-28 | - | Kvartalsrapport 2022-Q3 |
| 2022-07-21 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-09 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
| 2022-05-06 | - | Årsstämma |
| 2022-05-06 | - | Kvartalsrapport 2022-Q1 |
| 2022-01-27 | - | Bokslutskommuniké 2021 |
| 2021-10-28 | - | Kvartalsrapport 2021-Q3 |
| 2021-07-29 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-10 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
| 2021-05-07 | - | Årsstämma |
| 2021-05-07 | - | Kvartalsrapport 2021-Q1 |
| 2021-01-28 | - | Bokslutskommuniké 2020 |
| 2020-10-22 | - | Kvartalsrapport 2020-Q3 |
| 2020-07-31 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-11 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
| 2020-05-08 | - | Årsstämma |
| 2020-05-06 | - | Kvartalsrapport 2020-Q1 |
| 2020-01-31 | - | Bokslutskommuniké 2019 |
| 2019-12-17 | - | Extra Bolagsstämma 2019 |
| 2019-10-25 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-30 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-09 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
| 2019-05-08 | - | Årsstämma |
| 2019-05-08 | - | Kvartalsrapport 2019-Q1 |
| 2019-02-08 | - | Bokslutskommuniké 2018 |
| 2018-10-26 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-17 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-31 | - | Årsstämma |
| 2018-05-18 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
| 2018-04-26 | - | Kvartalsrapport 2018-Q1 |
| 2018-01-31 | - | Bokslutskommuniké 2017 |
| 2017-10-27 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-16 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-02 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
| 2017-04-28 | - | Årsstämma |
| 2017-04-28 | - | Kvartalsrapport 2017-Q1 |
| 2017-02-13 | - | Bokslutskommuniké 2016 |
| 2016-11-17 | - | Extra Bolagsstämma 2016 |
| 2016-11-14 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-24 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-09 | - | Kvartalsrapport 2016-Q1 |
| 2016-04-15 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
| 2016-04-14 | - | Årsstämma |
| 2016-02-08 | - | Bokslutskommuniké 2015 |
| 2015-11-06 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-14 | - | Kvartalsrapport 2015-Q2 |
| 2015-05-08 | - | Kvartalsrapport 2015-Q1 |
| 2015-04-17 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
| 2015-04-16 | - | Årsstämma |
| 2015-01-30 | - | Bokslutskommuniké 2014 |
| 2014-11-07 | - | Kvartalsrapport 2014-Q3 |
| 2014-11-07 | - | Analytiker möte 2014 |
| 2014-08-15 | - | Kvartalsrapport 2014-Q2 |
| 2014-05-16 | - | Kvartalsrapport 2014-Q1 |
| 2014-04-17 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
| 2014-04-16 | - | Årsstämma |
| 2014-02-17 | - | Bokslutskommuniké 2013 |
| 2013-11-28 | - | Kvartalsrapport 2013-Q3 |
| 2013-11-01 | - | Analytiker möte 2013 |
| 2013-10-30 | - | Extra Bolagsstämma 2013 |
| 2013-09-02 | - | 15-7 2013 |
| 2013-08-30 | - | Kvartalsrapport 2013-Q2 |
| 2013-06-03 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
| 2013-05-31 | - | Årsstämma |
| 2013-05-29 | - | Kvartalsrapport 2013-Q1 |
| 2013-02-26 | - | Bokslutskommuniké 2012 |
| 2012-12-04 | - | Extra Bolagsstämma 2012 |
| 2012-11-28 | - | Kvartalsrapport 2012-Q3 |
| 2012-09-04 | - | Kvartalsrapport 2012-Q2 |
| 2012-06-04 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
| 2012-06-01 | - | Årsstämma |
| 2012-05-24 | - | Kvartalsrapport 2012-Q1 |
| 2012-02-24 | - | Bokslutskommuniké 2011 |
| 2011-11-25 | - | Kvartalsrapport 2011-Q3 |
| 2011-08-26 | - | Kvartalsrapport 2011-Q2 |
| 2011-05-26 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
| 2011-05-25 | - | Årsstämma |
| 2011-05-24 | - | Kvartalsrapport 2011-Q1 |
| 2011-02-11 | - | Bokslutskommuniké 2010 |
| 2010-06-02 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
| 2010-06-01 | - | Årsstämma |
| 2010-05-28 | - | Kvartalsrapport 2010-Q1 |
| 2009-11-27 | - | Kvartalsrapport 2009-Q3 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Small Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
The Supreme Court denies leave to appeal in the case regarding a former employee's claim for compensation for an invention.
The Supreme Court ruling means that the case is finally adjudicated and the ruling by the Patent and Market Court of Appeal therefore stands. Both C-RAD and the counterpart had sought leave to appeal to the Supreme Court.
As a consequence of the decision from the Supreme Court, C-RAD will recognize a provision of approximately SEK 10 million, covering past time and until today’s date.
For products using the invention described in the patent applications US12/632526 or PCT/SE2010/051338, C-RAD is obliged to pay a 1 % royalty on net sales to the counterpart, up until 7th of December 2029.
For further information:
Cecilia de Leeuw, CEO, +46 (0)795 85 66 77, investors@c-rad.com
Christoffer Herou, CFO, +46 (0)725 82 86 16, investors@c-rad.com
About C-RAD
C-RAD develops surface-guided imaging solutions for radiation therapy to allow highly accurate dose delivery to the tumor, and at the same time, to protect healthy tissue from unwanted exposure. Using high-speed 3D cameras combined with augmented reality, C-RAD supports the initial patient setup process and monitors the patient's motion during treatment to ensure high confidence, an efficient workflow, and improved accuracy. C-RAD monitors the patient's motion without the use of tattoos or additional imaging dose, to deliver the highest level of patient safety and comfort.
C-RAD. Inspiring excellence in cancer treatment.
C-RAD AB is listed on NASDAQ Stockholm.
For more information on C-RAD, please visit http://www.c-rad.com
This information is information that C-RAD is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2024-02-22 12:38 CET.